(Total Views: 473)
Posted On: 03/06/2024 1:09:43 AM
Post# of 148892
Re: mightycydy #141527
Quote:
f I heard Dr. Jay correctly...
In addition to CRP, "EN-RAGE" is the other primary endpoint that will be measured in the upcoming inflammatory trial.
CCR5 blockade downregulates RAGE the receptor for EN-RAGE as seen in our NASH trial.
(7)
(0)Scroll down for more posts ▼
